1. Off-the-shelfallogeneic car t cells: development and challenges;Depil;Nat. Rev. Drug Discovery,2020
2. Will allogeneic car t cells for cd19+ malignancies take autologous car t cells off the shelf?;DiNofia;Nat. Rev. Clin. Oncol.,2021
3. EMA, 2018. First two CAR-T cell medicines recommended for approval in the European Union. https://tinyurl.com/yybcjud2 [Accessed: 10 Nov 2020].
4. FDA, 2017. FDA approves CAR-T cell therapy to treat adults with certain types of large B-cell lymphoma. https://www.fda.gov/news-events/press-announcements/fda-approves-car-t-cell-therapy-treat-adults-certain-types-large-b-cell-lymphoma [accessed: 10 Nov 2020].
5. Guthrie, G., 2018. CAR T-Cell Immunotherapy: The 2018 Advance of the Year. https://www.cancer.net/blog/2018-01/car-t-cell-immunotherapy-2018-advance-year [accessed: 10 Nov 2020].